Evidence map›Paper›PMID 24830368›Full record

ArticlePloS one2014

The Thoc1 encoded ribonucleoprotein is required for myeloid progenitor cell homeostasis in the adult mouse.

Laura Pitzonka, Sumana Ullas, Meenalakshmi Chinnam, Benjamin J Povinelli, Daniel T Fisher, Michelle Golding, Michelle M Appenheimer, Michael J Nemeth, Sharon Evans, David W Goodrich

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Revealing nascent proteomics in signaling pathways and cell differentiation.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Laura PitzonkaDepartment of Pharmacology & Therapeutics, Roswell Park Cancer Institute, Buffalo, New York, United States of America.
Sumana UllasDepartment of Pharmacology & Therapeutics, Roswell Park Cancer Institute, Buffalo, New York, United States of America.
Meenalakshmi ChinnamDepartment of Pharmacology & Therapeutics, Roswell Park Cancer Institute, Buffalo, New York, United States of America.
Benjamin J PovinelliDepartment of Immunology, Roswell Park Cancer Institute, Buffalo, New York, United States of America.
Daniel T FisherDepartment of Immunology, Roswell Park Cancer Institute, Buffalo, New York, United States of America.
Michelle GoldingDepartment of Immunology, Roswell Park Cancer Institute, Buffalo, New York, United States of America.
Michelle M AppenheimerDepartment of Immunology, Roswell Park Cancer Institute, Buffalo, New York, United States of America.
Michael J NemethDepartment of Immunology, Roswell Park Cancer Institute, Buffalo, New York, United States of America.
Sharon EvansDepartment of Immunology, Roswell Park Cancer Institute, Buffalo, New York, United States of America.
David W GoodrichDepartment of Pharmacology & Therapeutics, Roswell Park Cancer Institute, Buffalo, New York, United States of America.
Roswell Park Comprehensive Cancer Center · US

Funding

Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI MARK G FRATTINI · 1985 to 2026
$116.6M
LEUKOCYTE-ENDOTHELIAL CELL ADHESION IN TUMOR IMMUNITYR01CA079765 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI EVANS, SHARON S · 2000 to 2013
$3.8M
Inflammatory Control of Lymphocyte TraffickingR01AI082039 · NIAID · ROSWELL PARK CANCER INSTITUTE CORP · PI EVANS, SHARON S · 2010 to 2014
$2.3M
The Role of Thoc1 in Normal Development and CancerR01CA125665 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI GOODRICH, DAVID W. · 2007 to 2011
$1.8M
Inflammatory Control of Lymphocyte TraffickingR56AI082039 · NIAID · ROSWELL PARK CANCER INSTITUTE CORP · PI EVANS, SHARON S · 2009 to 2009
$256k
NCI NIH HHS P30 CA016056NCI NIH HHS R01 CA079765NCI NIH HHS R01 CA125665NIAID NIH HHS R01 AI082039NIAID NIH HHS R56 AI082039
6 · The paper itself

Abstract

Co-transcriptionally assembled ribonucleoprotein (RNP) complexes are critical for RNA processing and nuclear export. RNPs have been hypothesized to contribute to the regulation of coordinated gene expression, and defects in RNP biogenesis contribute to genome instability and disease. Despite the large number of RNPs and the importance of the molecular processes they mediate, the requirements for individual RNP complexes in mammalian development and tissue homeostasis are not well characterized. THO is an evolutionarily conserved, nuclear RNP complex that physically links nascent transcripts with the nuclear export apparatus. THO is essential for early mouse embryonic development, limiting characterization of the requirements for THO in adult tissues. To address this shortcoming, a mouse strain has been generated allowing inducible deletion of the Thoc1 gene which encodes an essential protein subunit of THO. Bone marrow reconstitution was used to generate mice in which Thoc1 deletion could be induced specifically in the hematopoietic system. We find that granulocyte macrophage progenitors have a cell autonomous requirement for Thoc1 to maintain cell growth and viability. Lymphoid lineages are not detectably affected by Thoc1 loss under the homeostatic conditions tested. Myeloid lineages may be more sensitive to Thoc1 loss due to their relatively high rate of proliferation and turnover.

Indexed as

AnimalsBone MarrowBone Marrow CellsCell LineageCell ProliferationCell SurvivalDNA-Binding ProteinsFemaleGene DeletionGene Expression Regulation, DevelopmentalGenotypeGranulocytesHomeostasisImmunophenotypingMacrophagesMaleDNA-Binding ProteinsRibonucleoproteinsRNA-Binding ProteinsThoc1 protein, mouse

Identifiers

PMID24830368
PMCPMC4022742
OpenAlexW1963763716

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.